Biotechnology Company
Appears in 1 story · Last updated Oct 3, 2026
As of October 2026: Advancing SENS-501 through dose-escalation trial
A single injection into the inner ear can now restore hearing in children born deaf. In April 2026 the FDA approved Otarmeni, the first gene therapy for inherited hearing loss, after about 80% of 24 trial participants gained measurable hearing and 42% could pick up whispers.
Updated Oct 3
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
